See more : Tube Investments of India Limited (TIINDIA.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Cosmo Chemical Co., Ltd. (005420.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cosmo Chemical Co., Ltd., a leading company in the Chemicals industry within the Basic Materials sector.
- KABE Group AB (publ.) (KABE-B.ST) Income Statement Analysis – Financial Results
- AES Indiana (IPWLK) Income Statement Analysis – Financial Results
- Elray Resources, Inc. (ELRA) Income Statement Analysis – Financial Results
- Luxbright AB (publ) (LXB.ST) Income Statement Analysis – Financial Results
- Qt Group Oyj (QTCOM.HE) Income Statement Analysis – Financial Results
Cosmo Chemical Co., Ltd. (005420.KS)
About Cosmo Chemical Co., Ltd.
Cosmo Chemical Co., Ltd. manufactures and sells titanium dioxide (TiO2) anatase in South Korea. The company offers COTIOX KA-100, a general grade TiO2 anatase product for white pigments, including plastics, rubbers, paints, papers, bricks, etc.; electronic components, such as TV Braun tubes, MLCC, etc.; and catalysts, photo catalysts, etc. It also provides COTIOX KA-320, a fiber grade type TiO2 anatase product used in textiles comprising polyester filament, stable, and acryl fibers, as well as for use in plastics, inks, etc. In addition, the company offers ferrous sulfate heptahydrate for use in waste treatment agents, other materials, and catalysts; ferrous sulfate monohydrate for use in waste treatment agents and other materials; liquid ferric sulfate, which is used as a waste treatment agent for dyeing, leather, paper, foods, and other wastes; liquid ferrous sulfate for use in FENTON samples and other waste treatment agents; and gypsum used in construction materials. The company was founded in 1968 and is headquartered in Incheon, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 798.98B | 718.19B | 512.61B | 355.50B | 406.82B | 678.09B | 431.65B | 286.51B | 250.02B | 281.85B | 315.36B | 309.16B | 172.36B | 124.72B | 110.56B | 103.63B | 86.53B |
| Cost of Revenue | 752.41B | 637.45B | 448.35B | 320.55B | 382.71B | 641.97B | 382.99B | 271.80B | 262.67B | 289.18B | 298.59B | 283.13B | 130.29B | 99.73B | 89.77B | 93.83B | 89.50B |
| Gross Profit | 46.57B | 80.75B | 64.27B | 34.95B | 24.11B | 36.13B | 48.65B | 14.71B | -12.65B | -7.33B | 16.77B | 26.03B | 42.07B | 24.99B | 20.79B | 9.80B | -2.97B |
| Gross Profit Ratio | 5.83% | 11.24% | 12.54% | 9.83% | 5.93% | 5.33% | 11.27% | 5.13% | -5.06% | -2.60% | 5.32% | 8.42% | 24.41% | 20.03% | 18.80% | 9.46% | -3.43% |
| Research & Development | 3.78B | 3.46B | 3.33B | 3.86B | 3.83B | 3.09B | 3.08B | 88.16M | 174.01M | 356.17M | 256.22M | 206.31M | 54.49M | 93.03M | 98.61M | 96.94M | 371.98M |
| General & Administrative | 3.50B | 3.29B | 2.70B | 2.45B | 2.99B | 2.78B | 1.98B | 1.89B | 2.01B | 2.76B | 2.98B | 3.69B | 2.22B | 2.03B | 1.43B | 1.38B | 1.85B |
| Selling & Marketing | 14.81B | 13.33B | 11.02B | 7.58B | 8.11B | 11.26B | 11.59B | 11.56B | 12.19B | 13.16B | 15.50B | 15.23B | 11.68B | 11.99B | 8.66B | 6.30B | 3.99B |
| SG&A | 18.31B | 16.62B | 13.72B | 10.03B | 11.10B | 14.04B | 13.57B | 13.46B | 14.20B | 15.92B | 18.48B | 18.91B | 13.90B | 14.01B | 10.09B | 7.68B | 5.85B |
| Other Expenses | 21.48B | 19.24B | 16.73B | 15.92B | 14.41B | -3.94B | -7.64B | -11.11B | 8.44B | 325.50M | 1.18B | 3.64B | 708.46M | 4.71B | 2.96B | 2.44B | 1.83B |
| Operating Expenses | 43.57B | 39.32B | 33.78B | 29.82B | 29.33B | 29.17B | 27.98B | 28.69B | 26.60B | 28.81B | 30.82B | 31.12B | 20.87B | 18.82B | 13.15B | 12.18B | 10.13B |
| Cost & Expenses | 796.07B | 676.77B | 482.13B | 350.37B | 412.05B | 671.14B | 410.97B | 300.49B | 289.27B | 317.99B | 329.42B | 314.25B | 151.16B | 118.55B | 102.92B | 106.01B | 99.64B |
| Interest Income | 1.92B | 654.88M | 765.67M | 630.70M | 206.18M | 96.45M | 395.38M | 490.81M | 1.74B | 2.57B | 2.54B | 2.94B | 2.58B | 2.24B | 473.77M | 883.60M | 722.12M |
| Interest Expense | 9.41B | 7.30B | 6.53B | 8.48B | 8.46B | 8.05B | 12.75B | 17.61B | 20.31B | 20.85B | 17.55B | 18.11B | 9.17B | 7.32B | 5.82B | 6.89B | 5.54B |
| Depreciation & Amortization | 24.49B | 25.52B | 23.64B | 25.04B | 26.78B | 25.40B | 21.19B | 23.42B | 28.99B | 27.27B | 26.47B | 24.80B | 13.44B | 11.17B | 10.93B | 10.80B | 12.21B |
| EBITDA | 27.03B | 68.56B | 58.55B | 14.95B | 16.84B | 24.53B | 58.35B | -32.14B | -74.12B | -8.28B | 12.22B | 16.60B | 36.62B | 49.40B | 18.97B | 12.06B | 365.00M |
| EBITDA Ratio | 3.38% | 9.58% | 11.49% | 7.60% | 2.42% | 2.63% | 11.64% | -4.64% | -6.14% | -1.32% | 4.54% | 5.24% | 21.32% | 39.58% | 17.15% | 7.29% | 0.21% |
| Operating Income | 3.01B | 41.43B | 30.48B | 5.00B | -10.90B | 6.25B | 20.68B | -13.98B | -39.25B | -36.14B | -14.05B | -5.09B | 21.20B | 5.91B | 6.44B | -2.38B | -13.10B |
| Operating Income Ratio | 0.38% | 5.77% | 5.95% | 1.41% | -2.68% | 0.92% | 4.79% | -4.88% | -15.70% | -12.82% | -4.46% | -1.65% | 12.30% | 4.74% | 5.83% | -2.29% | -15.14% |
| Total Other Income/Expenses | -9.88B | -7.76B | -4.34B | -23.85B | -13.52B | -14.95B | 3.73B | -58.53B | -71.18B | -20.30B | 8.92B | -21.23B | -7.19B | 24.99B | -4.23B | -3.37B | -4.45B |
| Income Before Tax | -6.87B | 36.01B | 28.50B | -18.85B | -18.74B | -8.70B | 24.41B | -72.51B | -122.50B | -56.43B | -5.13B | -26.32B | 14.01B | 30.91B | 2.22B | -5.75B | -17.56B |
| Income Before Tax Ratio | -0.86% | 5.01% | 5.56% | -5.30% | -4.61% | -1.28% | 5.65% | -25.31% | -49.00% | -20.02% | -1.63% | -8.51% | 8.13% | 24.78% | 2.00% | -5.54% | -20.29% |
| Income Tax Expense | 598.32M | 4.54B | 5.00B | -3.22B | -4.20B | 137.54M | -2.93B | -16.62B | -614.35M | -9.03B | 642.73M | -12.19B | 2.11B | 32.02B | 389.09M | -875.26M | 1.08B |
| Net Income | -26.83B | 31.47B | 23.50B | -15.62B | -14.55B | -15.89B | 21.44B | -73.35B | -106.86B | -42.25B | -522.87M | -17.65B | 14.01B | 30.91B | 2.22B | -5.75B | -17.56B |
| Net Income Ratio | -3.36% | 4.38% | 4.58% | -4.39% | -3.58% | -2.34% | 4.97% | -25.60% | -42.74% | -14.99% | -0.17% | -5.71% | 8.13% | 24.78% | 2.00% | -5.54% | -20.29% |
| EPS | -753.82 | 918.19 | 736.47 | -513.83 | -635.28 | -745.26 | 1.17K | -4.28K | -6.27K | -2.45K | -30.39 | -1.03K | 886.67 | 2.14K | 153.48 | -398.13 | -1.22K |
| EPS Diluted | -753.82 | 918.19 | 736.47 | -513.83 | -635.28 | -745.26 | 1.08K | -4.19K | -6.14K | -2.45K | -30.39 | -1.03K | 812.97 | 2.14K | 153.48 | -398.13 | -1.22K |
| Weighted Avg Shares Out | 35.59M | 34.28M | 31.91M | 30.40M | 22.90M | 21.33M | 18.36M | 17.14M | 17.06M | 17.21M | 17.20M | 17.21M | 15.79M | 14.42M | 14.44M | 14.43M | 14.34M |
| Weighted Avg Shares Out (Dil) | 35.59M | 34.28M | 31.91M | 30.40M | 22.90M | 21.33M | 19.89M | 17.51M | 17.42M | 17.21M | 17.20M | 17.21M | 18.26M | 14.42M | 14.44M | 14.43M | 14.34M |
Source: https://incomestatements.info
Category: Stock Reports